Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

Market Cap	4.99B -32.4%
Revenue (ttm)	257.74M -36.5%
Net Income	-220.75M
EPS	-0.33
Shares Out	659.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,320,235
Average Volume	5,720,362
Open	7.51
Previous Close	7.55
Day's Range	7.41 - 7.63
52-Week Range	5.69 - 11.67
Beta	0.31
RSI	51.92
Earnings Date	Apr 29, 2026

About SHE:002581

Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. The company is involved in the chemical raw materials, chemical product manufacturing, and biopharmaceutical manufacturing; production and sales of medicines. It also offers operating chemical products, such as trimethyl ester and triethyl ester. The company was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 476
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002581

Financial Performance

In 2024, SHE:002581's revenue was 360.41 million, a decrease of -16.14% compared to the previous year's 429.79 million. Losses were -137.31 million, -58.70% less than in 2023.